{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:43:25Z","timestamp":1785833005130,"version":"3.56.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P50DA046351"],"award-info":[{"award-number":["P50DA046351"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["5R01DA045055-03"],"award-info":[{"award-number":["5R01DA045055-03"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.drugalcdep.2021.109232","type":"journal-article","created":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T04:25:33Z","timestamp":1640665533000},"page":"109232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["The effect of state policies on rates of high-risk prescribing of an initial opioid analgesic"],"prefix":"10.1016","volume":"231","author":[{"given":"Bradley D.","family":"Stein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin A.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sorbero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalie Liccardo","family":"Pacula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.drugalcdep.2021.109232_bib1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jama.2021.11013","article-title":"Association of dose tapering with overdose or mental health crisis among patients prescribed long-term opioids","volume":"326","author":"Agnoli","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2021.109232_bib2","series-title":"Provisional Drug Overdose Death Counts","author":"Ahmad","year":"2020"},{"issue":"6","key":"10.1016\/j.drugalcdep.2021.109232_bib3","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1377\/hlthaff.2015.1673","article-title":"Prescription drug monitoring programs are associated with sustained reductions in opioid prescribing by physicians","volume":"35","author":"Bao","year":"2016","journal-title":"Health Aff."},{"issue":"7","key":"10.1016\/j.drugalcdep.2021.109232_bib4","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJMsa1610524","article-title":"Opioid-prescribing patterns of emergency physicians and risk of long-term use","volume":"376","author":"Barnett","year":"2017","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2021.109232_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108248","article-title":"The association between opioid discontinuation and heroin use: a nested case-control study","volume":"217","author":"Binswanger","year":"2020","journal-title":"Drug Alcohol Depend."},{"issue":"6","key":"10.1016\/j.drugalcdep.2021.109232_bib6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7326\/M18-1243","article-title":"Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention's 2016 Opioid Guideline","volume":"169","author":"Bohnert","year":"2018","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.drugalcdep.2021.109232_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/003335491412900207","article-title":"Prescription drug monitoring and dispensing of prescription opioids","volume":"129","author":"Brady","year":"2014","journal-title":"Public Health Rep."},{"key":"10.1016\/j.drugalcdep.2021.109232_bib8","doi-asserted-by":"crossref","first-page":"j5790","DOI":"10.1136\/bmj.j5790","article-title":"Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study","volume":"360","author":"Brat","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2021.109232_bib9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.drugalcdep.2017.05.023","article-title":"Impact of New York prescription drug monitoring program, I-STOP, on statewide overdose morbidity","volume":"178","author":"Brown","year":"2017","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.drugalcdep.2021.109232_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1257\/pol.20160094","article-title":"The effect of prescription drug monitoring programs on opioid utilization in Medicare","volume":"10","author":"Buchmueller","year":"2018","journal-title":"Am. Econ. J. Econ. Policy"},{"issue":"3","key":"10.1016\/j.drugalcdep.2021.109232_bib11","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jpeds.2015.04.071","article-title":"Nonmedical prescription opioid use in childhood and early adolescence predicts transitions to heroin use in young adulthood: a national study","volume":"167","author":"Cerda","year":"2015","journal-title":"J. Pediatr."},{"key":"10.1016\/j.drugalcdep.2021.109232_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2016.04.033","article-title":"Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: a comparative interrupted time series analysis","volume":"165","author":"Chang","year":"2016","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/j.drugalcdep.2021.109232_bib13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/pds.4404","article-title":"Impact of Florida\u2019s prescription drug monitoring program and pill mill law on high-risk patients: a comparative interrupted time series analysis","volume":"27","author":"Chang","year":"2018","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"7","key":"10.1016\/j.drugalcdep.2021.109232_bib14","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamapsychiatry.2014.366","article-title":"The changing face of heroin use in the United States: a retrospective analysis of the past 50 years","volume":"71","author":"Cicero","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.drugalcdep.2021.109232_bib15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMra1508490","article-title":"Relationship between nonmedical prescription-opioid use and heroin use","volume":"374","author":"Compton","year":"2016","journal-title":"New Engl. J. Med."},{"issue":"3 Pt 1","key":"10.1016\/j.drugalcdep.2021.109232_bib16","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1475-6773.2006.00511.x","article-title":"Geographic variation in the prescription of schedule II opioid analgesics among outpatients in the United States","volume":"41","author":"Curtis","year":"2006","journal-title":"Health Serv. Res."},{"issue":"1","key":"10.1016\/j.drugalcdep.2021.109232_bib17","first-page":"85","article-title":"Cohort study of the impact of high-dose opioid analgesics on overdose mortality","volume":"17","author":"Dasgupta","year":"2016","journal-title":"Pain Med."},{"issue":"7","key":"10.1016\/j.drugalcdep.2021.109232_bib18","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/add.15359","article-title":"Laws limiting prescribing and dispensing of opioids in the United States, 1989-2019","volume":"116","author":"Davis","year":"2021","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2021.109232_bib19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.drugalcdep.2018.09.022","article-title":"Laws limiting the prescribing or dispensing of opioids for acute pain in the United States: a national systematic legal review","volume":"194","author":"Davis","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2021.109232_bib20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.drugalcdep.2018.09.022","article-title":"Laws limiting the prescribing or dispensing of opioids for acute pain in the United States: a national systematic legal review","volume":"194","author":"Davis","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.drugalcdep.2021.109232_bib21","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/pm\/pnz159","article-title":"Opioid prescribing laws are not associated with short-term declines in prescription opioid distribution","volume":"21","author":"Davis","year":"2020","journal-title":"Pain Med."},{"issue":"5","key":"10.1016\/j.drugalcdep.2021.109232_bib22","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jemermed.2019.07.016","article-title":"Association of the \"CDC Guideline for Prescribing Opioids for Chronic Pain\" with emergency department opioid prescribing","volume":"57","author":"Dayer","year":"2019","journal-title":"J. Emerg. Med."},{"issue":"1","key":"10.1016\/j.drugalcdep.2021.109232_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"10.1016\/j.drugalcdep.2021.109232_bib24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11606-016-3810-3","article-title":"Association between initial opioid prescribing patterns and subsequent long-term use among opioid-naive patients: a statewide retrospective cohort study","volume":"32","author":"Deyo","year":"2017","journal-title":"J. Gen. Intern. Med."},{"issue":"19","key":"10.1016\/j.drugalcdep.2021.109232_bib25","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1001\/jama.2019.16409","article-title":"Patient-centered reduction or discontinuation of long-term opioid analgesics: the HHS guide for clinicians","volume":"322","author":"Dowell","year":"2019","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.drugalcdep.2021.109232_bib26","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain--United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.drugalcdep.2021.109232_bib27","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1377\/hlthaff.2016.0448","article-title":"Mandatory provider review and pain clinic laws reduce the amounts of opioids prescribed and overdose death rates","volume":"35","author":"Dowell","year":"2016","journal-title":"Health Aff."},{"issue":"2","key":"10.1016\/j.drugalcdep.2021.109232_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-152-2-201001190-00006","article-title":"Opioid prescriptions for chronic pain and overdose: a cohort study","volume":"152","author":"Dunn","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2021.109232_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108239","article-title":"State pain management clinic policies and county opioid prescribing: a fixed effects analysis","volume":"216","author":"Frizzell","year":"2020","journal-title":"Drug Alcohol Depend."},{"issue":"7","key":"10.1016\/j.drugalcdep.2021.109232_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.16860","article-title":"Changes in initial opioid prescribing practices after the 2016 release of the CDC Guideline for Prescribing Opioids for Chronic Pain","volume":"4","author":"Goldstick","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"7","key":"10.1016\/j.drugalcdep.2021.109232_bib31","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/jamaoncol.2020.0804","article-title":"Association of mandatory-access prescription drug monitoring programs with opioid prescriptions among medicare patients treated by a medical or hematologic oncologist","volume":"6","author":"Graetz","year":"2020","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.drugalcdep.2021.109232_bib32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/pam.22098","article-title":". Mandatory access prescription drug monitoring programs and prescription drug abuse","volume":"38","author":"Grecu","year":"2019","journal-title":"J. Policy Anal. Manag."},{"issue":"5","key":"10.1016\/j.drugalcdep.2021.109232_bib33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/M17-0865","article-title":"Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 national survey on drug use and health","volume":"167","author":"Han","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2021.109232_bib34","series-title":"Drug Overdose Deaths in the United States, 1999-2018","author":"Hedegaard","year":"2020"},{"issue":"9","key":"10.1016\/j.drugalcdep.2021.109232_bib35","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.2105\/AJPH.2019.305253","article-title":"Prescription opioids: a continuing contributor to the epidemic","volume":"109","author":"Heins","year":"2019","journal-title":"Am. J. Public Health"},{"issue":"10","key":"10.1016\/j.drugalcdep.2021.109232_bib36","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1080\/10826084.2017.1416407","article-title":"High-risk prescribing to medicaid enrollees receiving opioid analgesics: individual- and county-level factors","volume":"53","author":"Heins","year":"2018","journal-title":"Subst. Use Misuse"},{"issue":"2","key":"10.1016\/j.drugalcdep.2021.109232_bib37","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0919","article-title":"Exposure-response association between concurrent opioid and benzodiazepine use and risk of opioid-related overdose in Medicare Part D beneficiaries","volume":"1","author":"Hernandez","year":"2018","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.drugalcdep.2021.109232_bib38","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/1475-6773.13548","article-title":"The importance of data source in prescription drug monitoring program research","volume":"56","author":"Horwitz","year":"2021","journal-title":"Health Serv. Res."},{"key":"10.1016\/j.drugalcdep.2021.109232_bib39","unstructured":"Huber, P. 1967. The behavior of maximum likelihood estaimates under nonstandard conditions. Paper presented at the Fifth Berkely symposium on Mathematical Statistics and Probability."},{"issue":"2","key":"10.1016\/j.drugalcdep.2021.109232_bib40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.amepre.2016.02.014","article-title":"Trends in the concomitant prescribing of opioids and benzodiazepines, 2002-2014","volume":"51","author":"Hwang","year":"2016","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.drugalcdep.2021.109232_bib41","unstructured":"IQVIA: Real World Data and Insights. Retrieved from \u3008https:\/\/www.iqvia.com\/solutions\/real-world-evidence\/real-world-data-and-insights\u3009 (Accessed 13 July 2020)."},{"key":"10.1016\/j.drugalcdep.2021.109232_bib42","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.drugalcdep.2018.12.030","article-title":"Co-occurring substance use and mental disorders among adults with opioid use disorder","volume":"197","author":"Jones","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2021.109232_bib43","doi-asserted-by":"crossref","unstructured":"Kaestner, R., Ziedan, E. 2019. Mortality and Socioeconomic Consequences of Prescription Opioids: Evidence from State Policies, NBER Working Paper no. 26135. NBER Working Paper Series. \u3008http:\/\/www.nber.org\/papers\/w26135\u3009.","DOI":"10.3386\/w26135"},{"key":"10.1016\/j.drugalcdep.2021.109232_bib44","unstructured":"Kaiser Family Foundation, 2021, Status of State Action on the Medicaid Expansion Decision. \u3008https:\/\/www.kff.org\/health-reform\/state-indicator\/state-activity-around-expanding-medicaid-under-the-affordable-care-act\/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D\u3009 (Accessed 19 February 2021)."},{"issue":"2","key":"10.1016\/j.drugalcdep.2021.109232_bib45","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2105\/AJPH.2015.302953","article-title":"Opioid overdose deaths and Florida's crackdown on pill mills","volume":"106","author":"Kennedy-Hendricks","year":"2016","journal-title":"Am. J. Public Health"},{"issue":"2","key":"10.1016\/j.drugalcdep.2021.109232_bib46","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/1073110520935337","article-title":"Nonconsensual dose reduction mandates are not justified clinically or ethically: an analysis","volume":"48","author":"Kertesz","year":"2020","journal-title":"J. Law Med. Ethics"},{"issue":"Suppl 3","key":"10.1016\/j.drugalcdep.2021.109232_bib47","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s11606-020-06254-7","article-title":"Promoting patient-centeredness in opioid deprescribing: a blueprint for de-implementation science","volume":"35","author":"Kertesz","year":"2020","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2021.109232_bib48","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","article-title":"The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction","volume":"36","author":"Kolodny","year":"2015","journal-title":"Annu. Rev. Public Health"},{"issue":"5","key":"10.1016\/j.drugalcdep.2021.109232_bib49","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jama.2021.11118","article-title":"Opioid tapering practices-time for reconsideration?","volume":"326","author":"Larochelle","year":"2021","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.drugalcdep.2021.109232_bib50","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.36687","article-title":"Systematic evaluation of state policy interventions targeting the US opioid epidemic, 2007-2018","volume":"4","author":"Lee","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.drugalcdep.2021.109232_bib51","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.36687","article-title":"Systematic evaluation of state policy interventions targeting the US opioid epidemic, 2007-2018","volume":"4","author":"Lee","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.drugalcdep.2021.109232_bib52","unstructured":"Legal Science, 2018. PDAPS - Pain Management Clinic. \u3008http:\/\/pdaps.org\/datasets\/pain-management-clinic-laws\u3009 (Accessed 22 February 2021)."},{"key":"10.1016\/j.drugalcdep.2021.109232_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107754","article-title":"The association between pain clinic laws and prescription opioid exposures: new evidence from multi-state comparisons","volume":"206","author":"Liang","year":"2020","journal-title":"Drug Alcohol Depend."},{"issue":"9","key":"10.1016\/j.drugalcdep.2021.109232_bib54","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/pm\/pnz234","article-title":"Associations between the specialty of opioid prescribers and opioid addiction, misuse, and overdose outcomes","volume":"21","author":"Lobo","year":"2020","journal-title":"Pain Med."},{"key":"10.1016\/j.drugalcdep.2021.109232_bib55","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.drugalcdep.2015.12.025","article-title":"Effect of a \u201cpill mill\u201d law on opioid prescribing and utilization: the case of Texas","volume":"159","author":"Lyapustina","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2021.109232_bib56","doi-asserted-by":"crossref","unstructured":"Mallatt, J. 2020. Policy-Induced Substitution to Illicit Drugs and Implications for Law Enforcement Activity. \u3008https:\/\/ssrn.com\/abstract=3418615\u3009 or http:\/\/dx.doi.org\/10.2139\/ssrn.3418615.","DOI":"10.2139\/ssrn.3418615"},{"key":"10.1016\/j.drugalcdep.2021.109232_bib57","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jsat.2019.05.001","article-title":"Opioid medication discontinuation and risk of adverse opioid-related health care events","volume":"103","author":"Mark","year":"2019","journal-title":"J. Subst. Abus. Treat."},{"issue":"1","key":"10.1016\/j.drugalcdep.2021.109232_bib58","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMsa1514387","article-title":"State legal restrictions and prescription-opioid use among disabled adults","volume":"375","author":"Meara","year":"2016","journal-title":"New Engl. J. Med."},{"issue":"4","key":"10.1016\/j.drugalcdep.2021.109232_bib59","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1162\/ajhe_a_00101","article-title":"Prescription drug monitoring programs: the role of asymmetric information on drug availability and abuse","volume":"4","author":"Meinhofer","year":"2018","journal-title":"Am. J. Health Econ."},{"issue":"4","key":"10.1016\/j.drugalcdep.2021.109232_bib60","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1001\/jamainternmed.2014.8071","article-title":"Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy","volume":"175","author":"Miller","year":"2015","journal-title":"JAMA Intern. Med."},{"issue":"2","key":"10.1016\/j.drugalcdep.2021.109232_bib61","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/jrh.12141","article-title":"Examining rural\/urban differences in prescription opioid misuse among US adolescents","volume":"32","author":"Monnat","year":"2016","journal-title":"J. Rural Health"},{"key":"10.1016\/j.drugalcdep.2021.109232_bib62","series-title":"2013 NCHS Urban\u2013Rural Classification Scheme for Counties; Vol 2","author":"National Center for Health Statistics","year":"2014"},{"issue":"2","key":"10.1016\/j.drugalcdep.2021.109232_bib63","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/pme.12594","article-title":"Benzodiazepine use among chronic pain patients prescribed opioids: associations with pain, physical and mental health, and health service utilization","volume":"16","author":"Nielsen","year":"2015","journal-title":"Pain Med."},{"key":"10.1016\/j.drugalcdep.2021.109232_bib64","doi-asserted-by":"crossref","first-page":"m283","DOI":"10.1136\/bmj.m283","article-title":"Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation","volume":"368","author":"Oliva","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2021.109232_bib65","doi-asserted-by":"crossref","unstructured":"Pacula, R., Smart, R., Stein, B.D. 2020. Pitfalls and Potholes: Data Issues to Consider When Analyzing State Opioid Policies. Retrieved from \u3008https:\/\/www.rand.org\/pubs\/presentations\/PTA921\u20131.html\u3009 (Accessed 9 April 2021).","DOI":"10.7249\/PTA921-1"},{"issue":"10","key":"10.1016\/j.drugalcdep.2021.109232_bib66","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/add.13741","article-title":"Do more robust prescription drug monitoring programs reduce prescription opioid overdose?","volume":"112","author":"Pardo","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2021.109232_bib67","doi-asserted-by":"crossref","unstructured":"Pardo, B., Taylor, J., Caulkins, J., Kilmer, B., Reuter, P., Stein, B. 2019. The Future of Fentanyl and Other Synthetic Opioids. \u3008https:\/\/www.rand.org\/pubs\/research_reports\/RR3117.html\u3009.","DOI":"10.7249\/RR3117"},{"key":"10.1016\/j.drugalcdep.2021.109232_bib68","doi-asserted-by":"crossref","first-page":"h2698","DOI":"10.1136\/bmj.h2698","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study","volume":"350","author":"Park","year":"2015","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.drugalcdep.2021.109232_bib69","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1377\/hlthaff.2015.1496","article-title":"Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates","volume":"35","author":"Patrick","year":"2016","journal-title":"Health Aff."},{"issue":"5","key":"10.1016\/j.drugalcdep.2021.109232_bib70","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1526-4637.2011.01062.x","article-title":"Prescription drug monitoring programs and death rates from drug overdose","volume":"12","author":"Paulozzi","year":"2011","journal-title":"Pain Med."},{"key":"10.1016\/j.drugalcdep.2021.109232_bib71","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.drugalcdep.2017.12.002","article-title":"Features of prescription drug monitoring programs associated with reduced rates of prescription opioid-related poisonings","volume":"184","author":"Pauly","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2021.109232_bib72","unstructured":"Prescription Drug Monitoring Program Training and Technical Center (PDMPTTAC), 2021. State PDMP Profiles and Contacts. Retrieved from \u3008https:\/\/pdmpassist.org\/State\u3009 (Accessed 26 February 2021)."},{"key":"10.1016\/j.drugalcdep.2021.109232_bib73","unstructured":"RAND-USC Schaeffer Opioid Policy Tools and Information Center, 2021. OPTIC-Vetted PDMP Policy Data. Retrieved from \u3008https:\/\/www.rand.org\/health-care\/centers\/optic\/resources\/datasets.html\u3009 Accessed."},{"issue":"3","key":"10.1016\/j.drugalcdep.2021.109232_bib74","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1526-4637.2012.01327.x","article-title":"Do prescription monitoring programs impact state trends in opioid abuse\/misuse?","volume":"13","author":"Reifler","year":"2012","journal-title":"Pain Med."},{"key":"10.1016\/j.drugalcdep.2021.109232_bib75","first-page":"41","article-title":"Prescription opioid usage and abuse relationships: an evaluation of state prescription drug monitoring program efficacy","volume":"3","author":"Reisman","year":"2009","journal-title":"Subst. Abus."},{"issue":"9","key":"10.1016\/j.drugalcdep.2021.109232_bib76","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1007\/s11606-018-4532-5","article-title":"Potentially inappropriate opioid prescribing, overdose, and mortality in Massachusetts, 2011-2015","volume":"33","author":"Rose","year":"2018","journal-title":"J. Gen. Intern. Med."},{"issue":"1","key":"10.1016\/j.drugalcdep.2021.109232_bib77","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/jgs.15659","article-title":"Effect of age on opioid prescribing, overdose, and mortality in Massachusetts, 2011 to 2015","volume":"67","author":"Rose","year":"2019","journal-title":"J. Am. Geriatr. Soc."},{"issue":"10","key":"10.1016\/j.drugalcdep.2021.109232_bib78","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1001\/jamainternmed.2015.3931","article-title":"Effect of Florida's prescription drug monitoring program and pill mill laws on opioid prescribing and use","volume":"175","author":"Rutkow","year":"2015","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.drugalcdep.2021.109232_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhealeco.2020.102397","article-title":"Can policy affect initiation of addictive substance use? Evidence from opioid prescribing","volume":"76","author":"Sacks","year":"2021","journal-title":"J. Health Econ."},{"key":"10.1016\/j.drugalcdep.2021.109232_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhealeco.2020.102397","article-title":"Can policy affect initiation of addictive substance use? Evidence from opioid prescribing","volume":"76","author":"Sacks","year":"2021","journal-title":"J. Health Econ."},{"key":"10.1016\/j.drugalcdep.2021.109232_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103308","article-title":"Opioid dosing among patients with 3 or more years of continuous prescription opioid use before and after the CDC opioid prescribing guideline","volume":"97","author":"Salas","year":"2021","journal-title":"Int. J. Drug Policy"},{"issue":"4","key":"10.1016\/j.drugalcdep.2021.109232_bib82","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.1588","article-title":"Changes in buprenorphine-naloxone and opioid pain reliever prescriptions after the Affordable Care Act Medicaid Expansion","volume":"1","author":"Saloner","year":"2018","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.drugalcdep.2021.109232_bib83","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s11606-019-05559-6","article-title":"Heterogeneity in prescription opioid pain reliever misuse across age groups: 2015-2017 national survey on drug use and health","volume":"35","author":"Schuler","year":"2020","journal-title":"J. Gen. Intern. Med"},{"issue":"1","key":"10.1016\/j.drugalcdep.2021.109232_bib84","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10742-020-00228-2","article-title":"Methodological challenges and proposed solutions for evaluating opioid policy effectiveness","volume":"21","author":"Schuler","year":"2020","journal-title":"Health Serv. Outcomes Res. Methodol."},{"key":"10.1016\/j.drugalcdep.2021.109232_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108137","article-title":"The state of the science in opioid policy research","volume":"214","author":"Schuler","year":"2020","journal-title":"Drug Alcohol Depend."},{"issue":"10","key":"10.1016\/j.drugalcdep.2021.109232_bib86","doi-asserted-by":"crossref","first-page":"265","DOI":"10.15585\/mmwr.mm6610a1","article-title":"Characteristics of initial prescription episodes and likelihood of long-term opioid use - United States, 2006-2015","volume":"66","author":"Shah","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"11","key":"10.1016\/j.drugalcdep.2021.109232_bib87","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.jpain.2017.06.010","article-title":"Factors influencing long-term opioid use among opioid naive patients: an examination of initial prescription characteristics and pain etiologies","volume":"18","author":"Shah","year":"2017","journal-title":"J. Pain"},{"issue":"5","key":"10.1016\/j.drugalcdep.2021.109232_bib88","doi-asserted-by":"crossref","first-page":"642","DOI":"10.2105\/AJPH.2018.304338","article-title":"Impact of medicaid expansion on access to opioid analgesic medications and medication-assisted treatment","volume":"108","author":"Sharp","year":"2018","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2021.109232_bib89","unstructured":"Substance Abuse and Mental Health Services Administration, 2019. Results from the 2019 National Survey on Drug Use and Health: Detailed Tables. Retrieved from \u3008https:\/\/www.samhsa.gov\/data\/report\/2019-nsduh-detailed-tables\u3009 (Accessed 12 February 2021)."},{"issue":"2","key":"10.1016\/j.drugalcdep.2021.109232_bib90","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.pain.2010.05.020","article-title":"Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and Medicaid insurance plans: the TROUP Study","volume":"150","author":"Sullivan","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.drugalcdep.2021.109232_bib91","doi-asserted-by":"crossref","first-page":"j760","DOI":"10.1136\/bmj.j760","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis","volume":"356","author":"Sun","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2021.109232_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugpo.2017.01.008","article-title":"Opioid analgesics and heroin: examining drug misuse trends among a sample of drug treatment clients in Kentucky","volume":"46","author":"Victor","year":"2017","journal-title":"Int. J. Drug Policy"},{"issue":"4","key":"10.1016\/j.drugalcdep.2021.109232_bib93","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2307\/1912934","article-title":"A heteroscedasticity-consistent covariance matrix estimator and a direct test for heteroscedasticity","volume":"48","author":"White","year":"1980","journal-title":"Econometrica"},{"issue":"5","key":"10.1016\/j.drugalcdep.2021.109232_bib94","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jpain.2015.01.475","article-title":"Defining risk of prescription opioid overdose: pharmacy shopping and overlapping prescriptions among long-term opioid users in Medicaid","volume":"16","author":"Yang","year":"2015","journal-title":"J. Pain"},{"issue":"1","key":"10.1016\/j.drugalcdep.2021.109232_bib95","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/pds.4572","article-title":"Opioid tolerance and clinically recognized opioid poisoning among patients prescribed extended-release long-acting opioids","volume":"28","author":"Young","year":"2019","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"3","key":"10.1016\/j.drugalcdep.2021.109232_bib96","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1001\/jama.2021.10161","article-title":"Prescription drug monitoring program mandates and opioids dispensed following emergency department encounters for patients with sickle cell disease or cancer with bone metastasis","volume":"326","author":"Zhang","year":"2021","journal-title":"JAMA"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871621007274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871621007274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:21:05Z","timestamp":1759828865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871621007274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":96,"alternative-id":["S0376871621007274"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.109232","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of state policies on rates of high-risk prescribing of an initial opioid analgesic","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.109232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109232"}}